Role of homoeopathic medicines on immunity in leprosy
Not Applicable
- Registration Number
- CTRI/2008/091/000080
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 180
Inclusion Criteria
Proven cases of ladult male and female eprosy patient between the age group from 18 to 60 years who have had no previous history of treatment will be taken in the study.
Exclusion Criteria
Patients having any history of previous treatment by MDT, having blood sugar and HIV infection will not be included in the study. Patient above 60 years and below 18 years of age will be excluded from the study .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In vitro assays of interleukins (IFNy, TNFa,IL-4, IL-10 ) in the peripheral blood , 10.Estimation of interlieukins like IFNy, TNFa IL2, IL4, IL10 of M. leprae antigen stimulated PBMC at different stagesTimepoint: two years
- Secondary Outcome Measures
Name Time Method Complete regain of sensation,regain of normal skin colour, regain of normalcy from psychological depressionTimepoint: Three years